Life Science Company News

Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

Claremont McKenna College Student Alvin Villarosa '25 named Barry Goldwater Scholar

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

Global Medical Dynamometers Market to Witness Upsurge in Growth at a CAGR of ~6% by 2030 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

CHEMISTREE ANNOUNCES RESULTS FROM ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

Read more ››
By: GlobeNewswire - 30 Apr 2024

LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights

Read more ››
By: GlobeNewswire - 30 Apr 2024

Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update

Read more ››
By: GlobeNewswire - 30 Apr 2024

Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 30 Apr 2024

Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies

Read more ››
By: GlobeNewswire - 30 Apr 2024

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Read more ››
By: GlobeNewswire - 30 Apr 2024

ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab

Read more ››
By: GlobeNewswire - 30 Apr 2024

OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Read more ››
By: GlobeNewswire - 30 Apr 2024

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 30 Apr 2024

Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device

Read more ››
By: GlobeNewswire - 30 Apr 2024

CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development

Read more ››
By: GlobeNewswire - 30 Apr 2024

Replay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies

Read more ››
By: GlobeNewswire - 30 Apr 2024

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy

Read more ››
By: GlobeNewswire - 30 Apr 2024

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate